Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC
Clinical trial NCT04549428 · TERMINATED
Trial details
- NCT number
- NCT04549428
- Sponsor
- Oncology Institute of Southern Switzerland
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-01-23
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.